Phase I/II trial of ABX A for Sanfilippo syndrome type B
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 31 Mar 2017
At a glance
- Drugs ABO-101 (Primary)
- Indications Mucopolysaccharidosis III
- Focus Adverse reactions; First in man; Therapeutic Use
- 31 Mar 2017 According to an Abeona Therapeutics media release, enrollments are anticipated to begin later in 2017.
- 19 Jan 2017 According to an Abeona Therapeutics media release, company anticipates initiating this trial in the second quarter of 2017.
- 24 May 2016 According to a Abeona Therapeutics media release, the FDA has allowed an Investigational New Drug (IND) Application for this phase I/II study.